SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-242454
Filing Date
2007-11-09
Accepted
2007-11-09 16:15:06
Documents
10
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 437786
2 LICENSE AGREEMENT dex101.htm EX-10.1 164120
3 AGREEMENT FOR SALE AND ASSIGNMENT OF RIGHTS dex102.htm EX-10.2 247188
4 DISTRIBUTION AND LICENSE AGREEMENT dex103.htm EX-10.3 338901
5 AMENDMENT AGREEMENT dex104.htm EX-10.4 21469
6 LICENSE AGREEMENT dex105.htm EX-10.5 76638
7 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9638
8 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9665
9 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 5960
10 GRAPHIC g68174img001.jpg GRAPHIC 16153
  Complete submission text file 0001193125-07-242454.txt   1335172
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23272 | Film No.: 071231813
SIC: 2836 Biological Products, (No Diagnostic Substances)